Overhaul of US drug policy is long overdue, expert says

March 9, 2017 by David Ruth
Overhaul of US drug policy is long overdue, expert says
Credit: shutterstock.com/Rice University

A new report from the Office of the Surgeon General, "Facing Addiction in America," suggests that an overhaul of U.S. drug policy is long overdue, according to a new issue brief from a drug policy expert at Rice University's Baker Institute for Public Policy.

The 's report is meant to be a call to action against the public health crisis of , according to the brief's author, Katharine Neill, the Baker Institute's Alfred C. Glassell III Postdoctoral Fellow in Drug Policy. It brings an authoritative voice to the current national debate over how to confront addiction in the face of rising rates of opioid-related overdoses and confirms what many observers have claimed—that addiction requires compassion and treatment, not punishment, she said.

"The strong endorsement from the surgeon general's office for integrated substance use care, expanded use of medication-assisted treatment and an overall public-health-based approach to addiction should send a clear message to policymakers and the public that an overhaul of U.S. is long overdue," Neill wrote.

The report is densely packed with troubling statistics that highlight the prevalence of alcohol and in the United States, Neill said. In 2015, 20.8 million people—nearly 8 percent of the U.S. population—met the criteria for a substance use disorder (SUD) involving alcohol or illicit substances. As the report states, roughly 88,000 deaths per year are alcohol-related. In 2015, more than 52,000 deaths were attributed to drug overdose, which has claimed more lives in recent years largely due to a rise in opioid misuse. Substance misuse and SUDs cost the United States roughly $400 billion annually in health care and criminal justice expenses and lost worker productivity.

Despite the heavy toll of substance misuse on individuals, families and society, only about 10 percent of people who need help with an SUD actually receive it, Neill said. "In the face of this crisis and based on a growing body of neurobiological evidence, the report argues that addiction is a chronic disease of the brain that should be treated more like diabetes and less like an act of criminal misconduct," Neill wrote.

Neill's brief, "Will the Surgeon General's Report on Addiction Change How We Treat Drug Users?", analyzes the major claims and implications of the report and proposes additional drug policy considerations for addressing substance use disorders."

"For all its admirable qualities, there are other areas in which the report falls short," Neill wrote. "It misses an opportunity to bring heroin-assisted treatment into the discussion of effective medication-assisted therapies for opioid use disorders. While it argues that addiction should not be criminalized, it stops short of supporting decriminalization of drug possession and maintains that legal sanctions can be an effective incentive for drug treatment, not dealing with the reality of how these sanctions might be used in practice and the collateral consequences that an individual faces if sanctions are enforced."

Neill said future efforts to address should frame neurobiological explanations of addiction more squarely within the context of environmental risk factors and should emphasize the need for social policies that address the underlying external causes of addiction.

"It is indeed time to change how we view drug addiction," Neill wrote. "Let's get it right this time—by acknowledging the many complexities of addiction and the need for a holistic policy response."

Explore further: Treat synthetic cannabinoids as public health issue, report says

Related Stories

Treat synthetic cannabinoids as public health issue, report says

March 3, 2017
A rise in the use of synthetic cannabinoids (syncans) in Houston has prompted law enforcement officials to target sellers and users of the drug. However, taking a public-health-based approach toward curbing the use of syncans, ...

New charts provide picture of drug use in the United States

August 15, 2016
An extensive and easy-to-use collection of charts that present findings from decades of government survey data of drug use in the United States is now available on the website of Rice University's Baker Institute for Public ...

Many patients receive prescription opioids during treatment for opioid addiction

February 23, 2017
More than two in five people receiving buprenorphine, a drug commonly used to treat opioid addiction, are also given prescriptions for other opioid painkillers - and two-thirds are prescribed opioids after their treatment ...

US needs harm-reduction approach to drug use, researcher says

January 14, 2015
The United States' law-and-order approach to reducing the supply of drugs and punishing sellers and users has impeded the development of a public health model that views drug addiction as a disease that is preventable and ...

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Pediatric workforce must address opioid crisis

October 3, 2016
In late August, the American Academy of Pediatrics (AAP) called on providers who care for youth to offer the same treatments routinely offered to adults - including medications like buprenorphine (commonly known by its brand ...

Recommended for you

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Mar 10, 2017
The surgeon general is an incompetent. A single dose of 250mg of healthy adult male facial skin surface lipid taken by mouth (the pheromone is usually passed in kissing), alleviates addiction without withdrawal symptoms for at least two years.
The collected pheromone is a behavioral biohazard, causing stupidity, incompetence, arrogance, suspicion, and in higher doses, jealousy. Osculation partners of treated addicts inevitably become artificially jealous. 40 day isolation, supplied air respirators for staff, and sealed packaging with activated charcoal dunnage for the collected male facial skin surface pheromone is indicated. It takes about 40 days for the pheromone to wear off the saliva of the treated former addict.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.